The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 31, 2017
Filed:
May. 16, 2013
Applicant:
Immune Design Corp., Seattle, WA (US);
Inventors:
Thomas W. Dubensky, Jr., Seattle, WA (US);
Nancy A. Hosken, Seattle, WA (US);
Scott H. Robbins, Lake Forest Park, WA (US);
Margaret D. Moore, Seattle, WA (US);
Assignee:
IMMUNE DESIGN CORP., Seattle, WA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/245 (2006.01); C07K 14/005 (2006.01); A61K 39/12 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/245 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); A61K 38/00 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55572 (2013.01); C12N 2710/16622 (2013.01); C12N 2710/16634 (2013.01);
Abstract
Compositions of recombinant HSV-2 proteins and an agonist of the innate immune system, such as an adjuvant, are provided as a vaccine. Proteins include an envelope glycoprotein and a structural protein other than an envelope glycoprotein, e.g., a capsid or tegument protein. The vaccine is for use in either HSV-2 seropositive or seronegative subjects.
Dubensky, Jr., Thomas. (2017). Vaccines for hsv-2 (U.S. Patent No. 9555099). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9555099
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile